Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Heier Jeffrey S.
Chief Scientific Officer at OCULAR THERAPEUTIX. Filing since 15 Mar 2019.
CIK 0001653082
Company
Date
Role
Action
Shares
Amount
Of holding
OCUL
OCULAR THERAPEUTIX, INC
2 Oct 2026
Chief Scientific Officer
Sold on a plan
10,869
$76.63K
3.4%
OCUL
OCULAR THERAPEUTIX, INC
24 Aug 2026
Chief Scientific Officer
Sold on a plan
3,296
$35.53K
1.0%
OCUL
OCULAR THERAPEUTIX, INC
26 May 2026
Chief Scientific Officer
Sold on a plan
3,018
$24.75K
0.9%
OCUL
OCULAR THERAPEUTIX, INC
23 Feb 2026
Chief Scientific Officer
Sold on a plan
3,057
$25.31K
0.9%
OCUL
OCULAR THERAPEUTIX, INC
24 Nov 2025
Chief Scientific Officer
Sold on a plan
3,469
$41.77K
1.4%
OCUL
OCULAR THERAPEUTIX, INC
2 Oct 2025
Chief Scientific Officer
Sold on a plan
10,502
$115.94K
4.0%
OCUL
OCULAR THERAPEUTIX, INC
25 Aug 2025
Chief Scientific Officer
Sold on a plan
3,063
$36.88K
1.2%
OCUL
OCULAR THERAPEUTIX, INC
23 May 2025
Chief Scientific Officer
Sold on a plan
3,024
$21.71K
1.1%
OCUL
OCULAR THERAPEUTIX, INC
24 Feb 2025
Chief Scientific Officer
Sold on a plan
3,061
$21.03K
1.1%
OCUL
OCULAR THERAPEUTIX, INC
25 Nov 2024
Chief Scientific Officer
Sold on a plan
2,948
$26.56K
1.1%
OCUL
OCULAR THERAPEUTIX, INC
12 May 2022
Director
Bought
15,000
$45.75K
62.5%
OCUL
OCULAR THERAPEUTIX, INC
15 Mar 2019
Director
Bought
24,000
$99.60K
opened
12 decisions on file.
